Add Yahoo as a preferred source to see more of our stories on Google. As the federal health emergency ended May 11 and COVID numbers are on the rise, here's how you can still access tests, at-home and ...
The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.
Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...
GlobalData on MSN
Co-Diagnostics files FDA 510(k) for flu and RSV PCR test
The molecular diagnostics company's concurrent CLIA Waiver by Application, if granted, would allow testing in decentralised ...
Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...
The healthcare company has introduced two new research-use PCR tests as demand for cyclospora detection grows during an ...
A new biotechnology company in McKinney has ambitions to become the world's first fully integrated platform for polymerase chain reaction (PCR) testing - the same technology behind a common COVID-19 ...
Roche (RHHBF) launches two new PCR tests to detect the parasite Cyclospora as the U.S. continues to grapple with an outbreak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results